Stage 4S Neuroblastoma Active Not Recruiting Phase 3 Trials for Sargramostim (DB00020)

IndicationStatusPhase
DBCOND0029574 (Stage 4S Neuroblastoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00026312Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With NeuroblastomaTreatment